← Back to directory

Kim Wolff

Researcher Next ID · RN-031625

Researcher · Medicine

King's College London

London, United Kingdom

Accepting doctoral researchersFunding unknown
Works count
2,393
Citation count
4,480
H-index
33
i10-index
87

Research interests

Medicine
Pharmacology, Toxicology and Pharmaceutics
Forensic Toxicology and Drug Analysis
Pharmacological Effects and Toxicity Studies
Electroconvulsive Therapy Studies
Schizophrenia research and treatment
Epilepsy research and treatment

Publications

  • Rapid detection of cocaine, benzoylecgonine and methylecgonine in fingerprints using surface mass spectrometry

    The Analyst · 2015 · 10.1039/c5an00112a

  • Rapid detection of cocaine, benzoylecgonine and methylecgonine in fingerprints using surface mass spectrometry

    The Analyst · 2015 · 10.1039/c5an00112a

  • The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity

    Biological Psychiatry · 2014 · https://doi.org/10.1016/j.biopsych.2013.12.015

  • Multiplexed Detection of Metabolites of Narcotic Drugs from a Single Latent Fingermark

    Analytical Chemistry · 2010 · 10.1021/ac1023205

  • Multiplexed Detection of Metabolites of Narcotic Drugs from a Single Latent Fingermark

    Analytical Chemistry · 2010 · 10.1021/ac1023205

  • Imaging of Latent Fingerprints through the Detection of Drugs and Metabolites

    Angewandte Chemie International Edition · 2008 · 10.1002/anie.200804348

  • Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population

    Journal of Psychopharmacology · 2006 · 10.1177/0269881106061514

  • Ketamine

    CNS Drugs · 2006 · https://doi.org/10.2165/00023210-200620030-00003

  • Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population

    Journal of Psychopharmacology · 2006 · 10.1177/0269881106061514

  • Cannabis use in patients with multiple sclerosis

    Multiple Sclerosis Journal · 2006 · 10.1177/1352458506070947

  • Characterization of Methadone Overdose: Clinical Considerations and the Scientific Evidence

    Therapeutic Drug Monitoring · 2002 · 10.1097/00007691-200208000-00001

  • Ecstasy pill testing: harm minimization gone too far?

    Addiction · 2001 · 10.1046/j.1360-0443.2001.96811397.x

  • Population pharmacokinetics of methadone in opiate users: characterization of time‐dependent changes

    British Journal of Clinical Pharmacology · 1999 · 10.1046/j.1365-2125.1999.00974.x

  • A review of biological indicators of illicit drug use, practical considerations and clinical usefulness

    Addiction · 1999 · https://doi.org/10.1046/j.1360-0443.1999.94912792.x

  • The pharmacokinetics of methadone in healthy subjects and opiate users

    British Journal of Clinical Pharmacology · 1997 · 10.1046/j.1365-2125.1997.t01-1-00591.x

  • The pharmacokinetics of methadone in healthy subjects and opiate users

    British Journal of Clinical Pharmacology · 1997 · 10.1046/j.1365-2125.1997.t01-1-00591.x

Current projects

    No projects listed.